Insider Selling: Enhabit (NYSE:EHAB) CAO Sells $19,094.83 in Stock

Enhabit, Inc. (NYSE:EHAB) CAO Collin Mcquiddy sold 1,403 shares of the business’s stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $13.61, for a total value of $19,094.83. Following the completion of the transaction, the chief accounting officer owned 3,991 shares of the company’s stock, valued at $54,317.51. This represents a 26.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Enhabit Trading Up 0.1%

Shares of NYSE:EHAB opened at $13.61 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.63 and a quick ratio of 1.63. Enhabit, Inc. has a 1 year low of $6.47 and a 1 year high of $13.68. The company has a market cap of $690.50 million, a P/E ratio of -151.27 and a beta of 1.56. The stock’s fifty day moving average price is $11.57 and its 200-day moving average price is $9.56.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, March 4th. The company reported $0.14 EPS for the quarter, hitting the consensus estimate of $0.14. Enhabit had a positive return on equity of 4.71% and a negative net margin of 0.43%.The company had revenue of $270.40 million during the quarter, compared to the consensus estimate of $270.56 million. Sell-side analysts expect that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on EHAB shares. Oppenheimer lowered shares of Enhabit from an “outperform” rating to a “market perform” rating in a research note on Monday, February 23rd. Deutsche Bank Aktiengesellschaft upgraded shares of Enhabit to a “buy” rating in a report on Tuesday, January 13th. Truist Financial set a $13.80 target price on shares of Enhabit in a research report on Monday, February 23rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of Enhabit in a research note on Monday, December 29th. Finally, Citigroup reissued a “buy” rating on shares of Enhabit in a report on Tuesday, December 16th. Two analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $13.57.

Institutional Investors Weigh In On Enhabit

Hedge funds and other institutional investors have recently made changes to their positions in the business. AQR Capital Management LLC boosted its holdings in shares of Enhabit by 115.6% in the first quarter. AQR Capital Management LLC now owns 215,341 shares of the company’s stock worth $1,867,000 after buying an additional 115,456 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Enhabit by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,813 shares of the company’s stock valued at $262,000 after buying an additional 1,248 shares during the last quarter. Jones Financial Companies Lllp raised its position in Enhabit by 110,987.5% in the first quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock worth $78,000 after acquiring an additional 8,879 shares during the period. Empowered Funds LLC raised its position in Enhabit by 8.4% in the first quarter. Empowered Funds LLC now owns 190,514 shares of the company’s stock worth $1,675,000 after acquiring an additional 14,690 shares during the period. Finally, Acadian Asset Management LLC purchased a new position in shares of Enhabit during the 1st quarter worth $114,000.

About Enhabit

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.